Pharma Insights 2024: Trends in analytical workflows in pharma
We are delighted to bring you Pharma Insights 2024 a live virtual event delivered by experts in their field. The event will cover the latest trends and insights you need to know in analytical chemistry for 2024 and a chance to ask your questions to the experts in a panel discussion.
Overview
The analytical challenges within pharma are always changing and evolving. In many laboratories the requirement to deliver fast, accurate and robust results while adapting to the changing molecular landscape and regulatory updates requires an important balance.
We will focus on trends in analytical workflows in pharma from drug discovery and development right through to quality control of manufactured drugs, that help pharma labs succeed in these challenges.
On the day, you will hear:
- How bringing ultimate simplicity to routine HPLC separations will benefit your productivity and risk mitigation in your QC lab
- Trace impurity quantification remains a key area for 2024, learn about the latest developments & workflows to improve confidence in drug safety, particularly nitrosamines
- Large molecules and new modalities remain a key growth area for 2024 learn about how new chemistry workflows can support your pharma workflows in 2024 from oligonucleotides to AAVs
Agenda
- Trends and Advances in LC in Pharma QC - Andrea Gheduzzi (Principal Pharma Market Development Manager-EMEA, Waters)
- Nitrosamine & GTI analysis- Amy Bartlett (Senior Market Development Manager – Waters)
- Latest developments for new modalities - TBC
- Live Q&A session
Join us for Pharma Insights 2024, we are really looking forward to answering your questions in our live Q&A session and discussing this topic further with you.
Presenter: Andrea Gheduzzi (Principal LC Market Dev. Manager, EMEA, Waters Corporation)
Andrea has spent more than 30 years in the chromatography field. Across his career he had various roles, service engineer, chromatography lab position, and technical application support manager. He has mainly been dealing with pharma accounts, also supporting LC method development activities using DoE/QbD approaches. In his role as Pharma Business Development Manager at Waters he has further expanded his expertise in AQbD and related applications.
Presenter: Amy Bartlett (Principal Market Development Manager, Testing and Lab Services, Waters Corporation)
Amy’s role in Pharmaceutical Market Development, within Waters’ Global Testing and Lab Services business, centers primarily on analytical solutions and workflows to support the Pharmaceutical Industry’s quantitative analysis needs. Specifically, Amy is focused on Waters Tandem Mass Spectrometry-centric solutions that tackle the industry's most pressing issues, including the challenging regulated analysis of trace level genotoxic impurities.
With nearly 17 years’ experience at Waters, Amy has established expertise in quantitative LC-MS/MS analysis and throughout this time led teams of experienced applications scientists providing application and scientific support to Waters' customers across a broad range of markets, applications, and technologies. Prior to joining Waters, Amy worked for several years in the pharmaceutical industry in Analytical Development and Discovery DMPK roles. She obtained a BSc in Chemistry from the University of Warwick, UK, before embarking on her career in the industry.
Moderator: Antonia Wierzbicki (Principal MS Market Dev Manager, EMEA, Waters Corporation)
Antonia Wierzbicki is a marketing manager at Waters working in EMEA. Antonia has BSc in Pharmaceutical Science and a MSc in Cancer Pharmacology. Following several years working as an analytical chemist in drug development roles within both academic labs and contract research organizations, Antonia has more recently spent time working with analytical chemists to provide solutions using cutting edge technologies to meet their needs and requirements, with a specific interest in ultra-sensitive quantitation of small molecules. Antonia is based in Cambridge UK and keen to connect with like-minded scientists in the field.
